Centene stock reflects managed care earnings power as Medicaid shift continues
Centene Corp. (ISIN US15133V1035) reported multi-billion-dollar revenue and higher earnings guidance for 2024, supported by growth in its marketplace and Medicare Advantage businesses. The company is navigating Medicaid redeterminations by shifting members to marketplace products, which, along with cost controls and improved profitability in …